Recurrence risk of node-negative and ER-positive early-stage breast cancer patients by combining recurrence score, pathologic, and clinical information: A meta-analysis approach

被引：0
|
作者：
Tang, G.
Cuzick, J.
Wale, C.
Costantino, J. P.
Crager, M.
Shak, S.
Wolmark, N.
Dowsett, M.
Forbes, J. F.
机构：
[1] Natl Surg Adjuvant Breast & Bowel Project, Pittsburgh, PA USA
[2] Univ London, London, England
[3] Genom Hlth, Redwood City, CA USA
[4] Natl Surg Adjuvant Breast & Bowel Project & Alleg, Pittsburgh, PA USA
[5] Royal Marsden Hosp, London SW3 6JJ, England
[6] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
509
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Using the 21-gene recurrence score and the recently developed Recurrence Score-Clinical-Pathologic to assess recurrence risk in patients with node-negative, ER-positive early-stage breast cancer receiving aromatase inhibitor treatment alone.
    Crager, M.
    Tang, G.
    Shak, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Comparing the Prediction of Chemotherapy Benefit in Patients with Node-Negative, ER-Positive Breast Cancer Using the Recurrence Score and a New Measure That Integrates Clinical and Pathologic Factors with the Recurrence Score
    Tang, G.
    Costantino, J. P.
    Crager, M.
    Shak, S.
    Wolmark, N.
    CANCER RESEARCH, 2010, 70
  • [3] IMPACT OF CLINICAL AND PATHOLOGIC FACTORS ON RECURRENCE OF NODE-NEGATIVE EARLY BREAST CANCER
    Lin, P.
    Li, L.
    Yeh, M.
    Liu, L.
    Chen, C.
    Tsui, Y.
    Su, C.
    Liang, J.
    Wang, H.
    Chiu, C.
    BREAST, 2013, 22 : S52 - S52
  • [4] Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor-Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors
    Tang, Gong
    Cuzick, Jack
    Costantino, Joseph P.
    Dowsett, Mitch
    Forbes, John F.
    Crager, Michael
    Mamounas, Eleftherios P.
    Shak, Steven
    Wolmark, Norman
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) : 4365 - 4372
  • [5] Clinical and Pathologic Risk Factors of Tumor Recurrence in Patients With Node-Negative Early Breast Cancer After Mastectomy
    Lin, Po-Han
    Yeh, Ming-Hsin
    Liu, Liang-Chih
    Chen, Chih-Jung
    Tsui, Yu-Chu
    Su, Chen-Hsien
    Wang, Hwei-Chung
    Liang, Ji-An
    Chang, Hui-Wen
    Wu, Hsiao-Su
    Yeh, Su-Peng
    Li, Long-Yuan
    Chiu, Chang-Fang
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 108 (06) : 352 - 357
  • [6] The recurrence score and chemotherapy treatment in node-positive, ER plus early-stage breast cancer patients in Israel
    Klang, S.
    Liebermann, N.
    Rizel, S.
    Ben-Baruch, N.
    Merling, S.
    Soussan-Gutman, L.
    Bugarini, R.
    Chao, C.
    Shak, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Recurrence risk in small, node-negative, early breast cancer
    Nagaoka, R.
    Horiguchi, J.
    Takata, D.
    Sato, A.
    Tokiniwa, H.
    Higuchi, T.
    Uchida, S.
    Tsuboi, M.
    Kikuchi, M.
    Takeyoshi, I.
    BREAST, 2015, 24 : S118 - S119
  • [8] A novel 95-gene signature (Curebest 95GC Breast) that predicts recurrence-risk in patients with ER-positive, HER2-negative, node-negative, early-stage primary invasive breast cancer with an intermediate Oncotype DX Recurrence Score.
    Fujii, Takeo
    Masuda, Hiroko
    Cheng, Yee Chung
    Yang, Fei
    Sahin, Aysegul A.
    Naoi, Yasuto
    Matsunaga, Yuki
    Raghavendra, Akshara Singareeka
    Sinha, Arup Kumar
    Fernandez, Jose R. Espinosa
    James, Anjali
    Yamagishi, Keisuke
    Matsushima, Tomoko
    Tripathy, Debu
    Tada, Sachiyo
    Jackson, Rubie S.
    Noguchi, Shinzaburo
    Nakamura, Seigo
    Acoba, Jared David
    Ueno, Naoto T.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast Cancer
    Sestak, Ivana
    Zhang, Yi
    Schroeder, Brock E.
    Schnabel, Catherine A.
    Dowsett, Mitch
    Cuzick, Jack
    Sgroi, Dennis
    CLINICAL CANCER RESEARCH, 2016, 22 (20) : 5043 - 5048
  • [10] How Much Is Oncotype DX Recurrence Score Impacting the Adjuvant Treatment Management of Node-Negative Early-Stage Breast Cancer Patients?
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    LABORATORY INVESTIGATION, 2013, 93 : 59A - 59A
12345